Suppr超能文献

为老年糖尿病患者量身定制治疗方案。

Individualising therapy for older adults with diabetes mellitus.

作者信息

Cayea Danelle, Boyd Cynthia, Durso Samuel C

机构信息

Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.

出版信息

Drugs Aging. 2007;24(10):851-63. doi: 10.2165/00002512-200724100-00005.

Abstract

The goal when treating patients with diabetes mellitus is to achieve the maximum longevity consistent with an optimal quality of life. To achieve this goal, treatment is typically focused on management of hyperglycaemic symptoms and prevention of microvascular and macrovascular complications. While appropriate for most individuals, including many older adults with robust health, this focus is often too limited for older adults facing diminished life expectancy and co-existing medical illness, frailty and disability. Creating a treatment plan that optimises health and function, and reduces the risk for morbidity and mortality, requires individualised therapy that judiciously manages symptoms and multiple competing health risks while remaining consistent with the patient's or his/her caregiver's healthcare preferences. Physicians caring for older adults with diabetes must be adept at recognising conditions commonly associated with diabetes, including the interplay with co-morbid illness, and be able to assess the patient's health status and use this information to recommend a treatment plan that is consistent with the patient's personal goals for care. The majority of older adults with diabetes will benefit from management of cardiovascular risk, including intensive management of hypertension, lipids, use of aspirin (acetylsalicylic acid) and smoking cessation, and screening for common geriatric syndromes. For a significant minority of older adults with life expectancy of >or=10 years, it is reasonable to consider intensive management of hyperglycaemia (glycosylated haemoglobin [HbA1c] target<or=7%). For frail older adults with life expectancy of <or=5 years, strategies for reducing medical burden, improving function and moderate glucose control (HbA1c approximately 8%) is reasonable and sufficient to control hyperglycaemic symptoms.

摘要

治疗糖尿病患者的目标是在保证最佳生活质量的前提下实现最长寿命。为实现这一目标,治疗通常侧重于控制高血糖症状以及预防微血管和大血管并发症。虽然这对大多数人,包括许多健康状况良好的老年人来说是合适的,但对于预期寿命缩短、同时患有其他疾病、身体虚弱和残疾的老年人而言,这种关注往往过于有限。制定一个能优化健康和功能、降低发病和死亡风险的治疗方案,需要个体化治疗,即在明智地管理症状和多种相互竞争的健康风险的同时,还要符合患者或其护理人员的医疗偏好。照顾老年糖尿病患者的医生必须善于识别与糖尿病常见相关的病症,包括与合并症的相互作用,并且能够评估患者的健康状况,并利用这些信息推荐一个符合患者个人护理目标的治疗方案。大多数老年糖尿病患者将从心血管风险管理中获益,包括强化管理高血压、血脂、使用阿司匹林(乙酰水杨酸)和戒烟,以及筛查常见的老年综合征。对于预期寿命≥10年的少数老年患者,考虑强化管理高血糖(糖化血红蛋白[HbA1c]目标≤7%)是合理的。对于预期寿命≤5年的体弱老年患者,减轻医疗负担、改善功能和适度控制血糖(HbA1c约为8%)的策略是合理且足以控制高血糖症状的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验